Oscar Health, Inc.
Price Action
Technical Summary
EMERGING TRENDOscar Health, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 95), indicating clear outperformance against the broad market. Earnings growth of 125% provides fundamental context to the price action. However, price is extended 33% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $25.00 | +13.61% | ABOVE |
| 50 SMA | $21.33 | +33.12% | ABOVE |
| 100 SMA | $17.27 | +64.47% | ABOVE |
| 150 SMA | $16.79 | +69.17% | ABOVE |
| 200 SMA | $17.37 | +63.55% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is OSCR in an uptrend right now?
OSCR has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is OSCR overbought or oversold?
OSCR's RSI (14) is 67. The stock is in neutral territory, neither overbought nor oversold.
Is OSCR outperforming the market?
OSCR has a Relative Strength (RS) Rating of 95 out of 99. Yes, OSCR is a market leader, outperforming 95% of all stocks over the past 12 months.
Where is OSCR in its 52-week range?
OSCR is trading at $28.40, which is 95% of its 52-week high ($29.81) and 93% above its 52-week low ($10.69).
How volatile is OSCR?
OSCR has a Beta of 1.71 and 52-week volatility of 75%. It's more volatile than the S&P 500 - expect bigger swings.